Merck KGaA Statistics

Total Valuation

Merck KGaA has a market cap or net worth of EUR 60.09 billion. The enterprise value is 67.69 billion.

Market Cap	60.09B
Enterprise Value	67.69B

Important Dates

The next estimated earnings date is Thursday, March 6, 2025.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	129.19M

Valuation Ratios

The trailing PE ratio is 22.29.

PE Ratio	22.29
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	13.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.97, with an EV/FCF ratio of 26.00.

EV / Earnings	25.11
EV / Sales	3.23
EV / EBITDA	12.97
EV / EBIT	19.19
EV / FCF	26.00

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.40.

Current Ratio	1.33
Quick Ratio	0.80
Debt / Equity	0.40
Debt / EBITDA	2.18
Debt / FCF	4.38
Interest Coverage	14.89

Financial Efficiency

Return on equity (ROE) is 9.54% and return on invested capital (ROIC) is 5.58%.

Return on Equity (ROE)	9.54%
Return on Assets (ROA)	4.41%
Return on Capital (ROIC)	5.58%
Revenue Per Employee	336,728
Profits Per Employee	43,306
Employee Count	62,908
Asset Turnover	0.42
Inventory Turnover	1.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-3.80%
50-Day Moving Average	147.84
200-Day Moving Average	157.59
Relative Strength Index (RSI)	32.71
Average Volume (20 Days)	561

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Merck KGaA had revenue of EUR 20.96 billion and earned 2.70 billion in profits. Earnings per share was 6.19.

Revenue	20.96B
Gross Profit	12.33B
Operating Income	3.53B
Pretax Income	3.37B
Net Income	2.70B
EBITDA	5.07B
EBIT	3.53B
Earnings Per Share (EPS)	6.19

Full Income Statement

Balance Sheet

The company has 3.86 billion in cash and 11.39 billion in debt, giving a net cash position of -7.53 billion.

Cash & Cash Equivalents	3.86B
Total Debt	11.39B
Net Cash	-7.53B
Net Cash Per Share	n/a
Equity (Book Value)	28.39B
Book Value Per Share	65.12
Working Capital	3.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.41 billion and capital expenditures -1.81 billion, giving a free cash flow of 2.60 billion.

Operating Cash Flow	4.41B
Capital Expenditures	-1.81B
Free Cash Flow	2.60B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.80%, with operating and profit margins of 16.83% and 12.86%.

Gross Margin	58.80%
Operating Margin	16.83%
Pretax Margin	16.07%
Profit Margin	12.86%
EBITDA Margin	24.20%
EBIT Margin	16.83%
FCF Margin	12.42%

Dividends & Yields

Merck KGaA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	38.24%
Buyback Yield	-0.16%
Shareholder Yield	-0.16%
Earnings Yield	4.53%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.

Last Split Date	Jun 30, 2014
Split Type	Forward
Split Ratio	2

Scores

Merck KGaA has an Altman Z-Score of 3.23.

Altman Z-Score	3.23
Piotroski F-Score	n/a